Secukinumab Shows Higher Symptomatic improvement Versus Infliximab in Psoriatic Arthritis- Comparative Effectiveness Up To 1 Year Assessed by Matching-Adjusted Indirect Comparisons

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2960
https://www.valueinhealthjournal.com/article/S1098-3015(17)33294-1/fulltext
Title : Secukinumab Shows Higher Symptomatic improvement Versus Infliximab in Psoriatic Arthritis- Comparative Effectiveness Up To 1 Year Assessed by Matching-Adjusted Indirect Comparisons
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33294-1&doi=10.1016/j.jval.2017.08.2960
First page : A935
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 2710
Categories :
Tags :
Regions :
ViH Article Tags :